Pieris Pharmaceuticals CEO Stephen Yoder's 2019 pay falls 39% to $1.6M
Pieris Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Pieris Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at Pieris Pharmaceuticals received on average a compensation package of $1.2M, a 25% decrease compared to previous year.
Average pay of disclosed executives at Pieris Pharmaceuticals
Stephen S. Yoder, Chief Executive Officer, received $1.6M in total, which decreased by 39% compared to 2018. 51% of Yoder's compensation, or $816K, was in option awards. Yoder also received $209K in non-equity incentive plan, $515K in salary, as well as $54K in other compensation.
Hitto Kaufmann, Chief Scientific Officer, received a compensation package of $1.1M. 87% of the compensation package, or $956K, was in option awards.
Louis A. Matis, Chief Development Officer, earned $759K in 2019, a 32% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2020.